BlackRock Advisors’s Gilead Sciences GILD Stock Holding History

BlackRock Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$604M	Buy	8,437,310 +287,090	+4%	+$21.3M	0.61%	32
2016 Q3	$645M	Buy	8,150,220 +2,769,646	+51%	+$225M	0.66%	29
2016 Q2	$449M	Buy	5,380,574 +1,787,193	+50%	+$159M	0.46%	51
2016 Q1	$330M	Sell	3,593,381 -113,090	-3%	-$10.2M	0.35%	74
2015 Q4	$375M	Buy	3,706,471 +457,156	+14%	+$47.6M	0.4%	68
2015 Q3	$319M	Buy	3,249,315 +1,487,357	+84%	+$165M	0.34%	75
2015 Q2	$206M	Buy	1,761,958 +107,518	+6%	+$11.7M	0.21%	120
2015 Q1	$162M	Sell	1,654,440 -720,951	-30%	-$73.2M	0.17%	153
2014 Q4	$224M	Sell	2,375,391 -64,277	-3%	-$6.65M	0.23%	115
2014 Q3	$260M	Sell	2,439,668 -1,820,195	-43%	-$178M	0.26%	96
2014 Q2	$353M	Sell	4,259,863 -1,550,984	-27%	-$121M	0.33%	70
2014 Q1	$412M	Sell	5,810,847 -1,342,592	-19%	-$105M	0.4%	59
2013 Q4	$537M	Sell	7,153,439 -1,043,990	-13%	-$72.7M	0.52%	47
2013 Q3	$515M	Sell	8,197,429 -137,098	-2%	-$8.19M	0.52%	43
2013 Q2	$427M	Buy	+8,334,527	New	+$434M	0.45%	57

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock Advisors's GILD Position: Q4 2016 in Review

BlackRock Advisors increased its Gilead Sciences (GILD) stake by 3.5% in Q4 2016, buying an estimated $21.3M and bringing the position to 8,437,310 shares worth $604M. The position accounts for 0.61% of the portfolio, ranked #32.

BlackRock Advisors first reported a position in GILD in Q2 2013 and has held it in 15 quarters since. The position peaked at $645M in Q3 2016. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

BlackRock Advisors held 8,437,310 shares of Gilead Sciences worth $604M as of Q4 2016.
BlackRock Advisors bought 287,090 Gilead Sciences shares in Q4 2016, an estimated $21.3M.
Gilead Sciences made up 0.61% of BlackRock Advisors's portfolio in Q4 2016, its #32 holding.
BlackRock Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Gilead Sciences position peaked at $645M in Q3 2016.
1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.